Oral Microbiome Diversity Matters on Nucleos(t)ide Analogue Cessation in Chronic Hepatitis B
Our exploratory study suggests that oral microbiome profiling at NUC cessation in HBeAg-negative CHB could support prognostication of virological outcome. Clinical Trials Registration. NCT03681132.
Authors
- Khaled Al‐Manei (ORCID: https://orcid.org/0000-0003-0787-5849)
- Niklas K. Björkström (ORCID: https://orcid.org/0000-0002-0967-076X)
- Davide Valentini (ORCID: https://orcid.org/0000-0002-6771-7175)
- Dag Henrik Reikvam (ORCID: https://orcid.org/0000-0002-4499-0320)
- Soo Aleman (ORCID: https://orcid.org/0000-0003-0461-4870)
- Asgeir Johannessen (ORCID: https://orcid.org/0000-0001-5966-7166)
- Chow Wei Too (ORCID: https://orcid.org/0000-0002-0073-1554)
- Mahin Ghorbani (ORCID: https://orcid.org/0009-0007-5028-3482)
- Christopher Maucourant (ORCID: https://orcid.org/0000-0003-1033-2992)
- Margaret Chen (ORCID: https://orcid.org/0000-0002-3793-4064)
- Agne Kvedaraite (ORCID: https://orcid.org/0009-0004-0881-5551)
- Susanne Cederberg
Institutions
- Oslo University Hospital (NO)
- Karolinska University Hospital (SE)
- University of Oslo (NO)
- King Saud University (SA)
- Sykehuset i Vestfold (NO)
- Karolinska Institutet (SE)
- Public Dental Service Västra Götaland (SE)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1093/infdis/jiaf591
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00